View in EDS

Patient-level analysis of five international cohorts further confirms the efficacy of aspirin for the primary prevention of thrombosis in patients with antiphospholipid antibodies.

Saved in:
Bibliographic Details
Title: Patient-level analysis of five international cohorts further confirms the efficacy of aspirin for the primary prevention of thrombosis in patients with antiphospholipid antibodies.
Authors: Arnaud, Laurent1,2,3 Laurent.arnaud@psl.aphp.fr, Mathian, Alexis1,3, Devilliers, Hervé4, Ruffatti, Amelia5, Tektonidou, Maria6, Forastiero, Ricardo7, Pengo, Vittorio8, Lambert, Marc9, Lefevre, Guillaume9, Martinez-Zamora, Maria Angeles10, Balasch, Juan10, Wahl, Denis11, Amoura, Zahir1,3
Source: Autoimmunity Reviews. Mar2015, Vol. 14 Issue 3, p192-200. 9p.
Database: Academic Search Ultimate
Description
ISSN:15689972
DOI:10.1016/j.autrev.2014.10.019